COMPASS FINANCIAL MANAGEMENT LLC’s Teva Pharmaceuticals TEVA Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	+32,254	New	+$1.07M	0.13%	175

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's TEVA Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 32,254 shares worth $1.09M. The stake represents 0.13% of the portfolio and ranks #175 among its holdings.

451 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 32,254 shares of Teva Pharmaceuticals worth $1.09M as of Q2 2026.
Teva Pharmaceuticals was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
Teva Pharmaceuticals made up 0.13% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #175 holding.
451 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.